Skip to main content

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In What does "Remember Me" do?

Don't Know Your Password?
Help

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In

Don't Know Your Password?

Zacks

more

Achaogen, Inc. (AKAO)

(Delayed Data from NSDQ)

$0.11 USD

0.00 (0.00%)

Updated Apr 25, 2019 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	23.68%
2	Buy	17.55%
3	Hold	9.21%
4	Sell	4.93%
5	Strong Sell	2.36%
S&P	500	10.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

NA

View All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

[AKAO]

Reports for Purchase

Showing records 1 - 20 ( 119 total )

Industry: Medical - Drugs

Record: 1

04/22/2019

Pages: 5

Dropping Coverage

Provider: H.C. Wainwright & Co., Inc.

Analyst: ARCE E

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 2

04/05/2019

Pages: 4

Dropping Coverage Due to Realignment of Analyst Resources

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 3

04/02/2019

Pages: 7

Conserving Cash for Ongoing Strategic Review as Focused ZEMDRI Launch Continues

Provider: H.C. Wainwright & Co., Inc.

Analyst: ARCE E

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 4

04/01/2019

Pages: 2

Liquidation Valuation

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 5

03/15/2019

Industry Report

Pages: 11

HEALTHCARE - The Week Ahead in Life Sciences

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 6

02/22/2019

Pages: 2

Post-Offering Update

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 7

02/21/2019

Pages: 6

As Strategic Review Continues, Positive ZEMDRI Updates Lead to Equity Raise and Expanded Runway; Adjust PT to $2

Provider: H.C. Wainwright & Co., Inc.

Analyst: ARCE E

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 8

02/15/2019

Pages: 2

We are maintaining our Hold recommendation

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 9

12/14/2018

Industry Report

Pages: 10

The Week Ahead in Life Sciences

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 10

12/07/2018

Industry Report

Pages: 6

The Week Ahead in Life Sciences

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 11

11/12/2018

Pages: 6

Seeking Strategic Options Before Cash Runs out; Downgrade to Neutral and cut PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: ARCE E

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 12

11/12/2018

Pages: 8

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 13

11/12/2018

Pages: 6

Downgrading to NEUTRAL and Lowering PT to $3; Exploring Strategic Alternatives

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 14

11/09/2018

Pages: 2

Achaogen reported Q3 results

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 15

11/06/2018

Pages: 2

Better Late than Never: AKAO Seeks Strategic Alternatives - Buy

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 16

10/23/2018

Pages: 10

ValuEngine Detailed Valuation Report for AKAO

Provider: ValuEngine, Inc

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 17

10/22/2018

Pages: 24

We are updating our coverage

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 18

09/17/2018

Industry Report

Pages: 9

ESCMID/ASM 2018: Updates on SPR994, SPR206, and ZEMDRI

Provider: H.C. Wainwright & Co., Inc.

Analyst: ARCE E

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 19

08/15/2018

Industry Report

Pages: 15

PacGrow Healthcare Conference: Day 1 Recap

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 20

08/09/2018

Pages: 8

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

previous
1
2
3
4
5
6
next

// eof